Intellia Therapeutics Inc (NTLA)

Operating Expenses

$120.42M

Quarterly · Period ending: · USD

NTLA logo

NTLA Operating Expenses

Latest reported$120.42M
NTLA Quarterly Operating Expenses ($167.00K → $120.42M)
High-resolution chart · PNG

NTLA operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Intellia Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
120,419,000
113,378,000
115,712,000
46,310,000
43,708,000
137,434,000
32,444,000
44,707,000
143,401,000
140,426,000
135,509,000
140,809,000
30,652,000
27,448,000
23,626,000
22,145,000
22,132,000
22,403,000
22,108,000
18,711,000
16,683,000
13,594,000
10,763,000
10,566,000
11,526,000
11,314,000
8,976,000
35,944,000
38,578,000
34,242,000
28,626,000
31,507,000
31,272,000
29,899,000
31,383,000
23,192,000
21,934,000
19,163,000
16,449,000
12,566,000
11,152,000
8,471,000
7,184,000
4,989,000
4,799,000
2,481,000
5,742,000
167,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.